Skip to content
Search

Latest Stories

Smokers encouraged to quit and join ‘Stoptober’ campaign

Smokers across England are being encouraged to take part in ‘Stoptober’, the nation’s biggest quitting campaign.

Marking its 10 year anniversary, the campaign will launch a mass quit attempt on October 1, calling on smokers to join the 2.3 million others who have made a quit attempt since the movement started in 2012.


Smoking in England remains the leading cause of premature death, with almost 75,000 preventable deaths a year.

A recent survey of 2,000 current smokers revealed that nearly 45 per cent of the lot have been smoking more since the first lockdown due to boredom and as the pandemic made them more anxious.

The survey also found that craving followed by stress are the biggest obstacles to quitting.

However, more than half of smokers want to quit to improve their physical health or to save money.

Stoptober is based on research that if a smoker can make it to 28 days smoke-free, they are 5-times more likely to quit.

The campaign offers a range of free quitting tools including:

  • NHS Quit Smoking app
  • Facebook messenger bot
  • Stoptober Facebook online communities
  • Daily emails and SMS
  • Online Personal Quit Plan, which includes expert support from local Stop Smoking Services and stop smoking aids

Scott Crosby, Tobacco Control Programme manager at Public Health England, said: “It’s been a tough time over the pandemic for smokers. But the numbers trying to quit is up and the success rate is up. Now is the time to do it! Sign up to Stoptober and make it a success.”

Leading UK health organisations, including The Asthma UK and the British Lung Foundation, are joining the campaign to encourage smokers to quit.

Eluned Hughes, head of Health Advice at Asthma UK and British Lung Foundation, said: “Quitting smoking is one of the best things anyone can do to improve their overall health. Smoking seriously damages the lungs, putting people at greater risk of developing conditions such as chronic obstructive pulmonary disease (COPD).”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less